Povsic, T. J., Nakamura, K., Henry, T. D., Traverse, J. H., Anderson, R. D., Bakaeen, F., … Dittrich, H. C. (2023). Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial. In EUROPEAN HEART JOURNAL (Vol. 44).

Povsic, T. J., K. Nakamura, T. D. Henry, J. H. Traverse, R. D. Anderson, F. Bakaeen, D. A. Latter, et al. “Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial.” In EUROPEAN HEART JOURNAL, Vol. 44, 2023.

Povsic TJ, Nakamura K, Henry TD, Traverse JH, Anderson RD, Bakaeen F, et al. Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial. In: EUROPEAN HEART JOURNAL. 2023.

Povsic, T. J., et al. “Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial.” EUROPEAN HEART JOURNAL, vol. 44, 2023.

Povsic TJ, Nakamura K, Henry TD, Traverse JH, Anderson RD, Bakaeen F, Latter DA, Ohman EM, Peterson MW, Byrnes D, Pepine CJ, Crystal RG, Rosengart TK, Mokadam NA, Dittrich HC. Angiogenic gene therapy for refractory angina: results of the epicardial delivery of XC001 gene therapy for refractory angina coronary treatment (EXACT) phase 2 trial. EUROPEAN HEART JOURNAL. 2023.